Goldman Sachs Group Inc Haemonetics Corp Transaction History

Goldman Sachs Group Inc

  • $580 Billion
  • Q2 2024

A detailed history of Goldman Sachs Group Inc transactions in Haemonetics Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 617,432 shares of HAE stock, worth $43.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
617,432
Previous 161,146 283.15%
Holding current value
$43.9 Million
Previous $13.8 Million 271.41%
% of portfolio
0.01%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$81.24 - $97.37 $37.1 Million - $44.4 Million
456,286 Added 283.15%
617,432 $51.1 Million
Q1 2024

May 15, 2024
SELL
$71.24 - $85.35 $2.14 Million - $2.57 Million
-30,107 Reduced 15.74%
161,146 $13.8 Million
Q4 2023

Feb 13, 2024
BUY
$80.59 - $92.61 $1.97 Million - $2.26 Million
24,394 Added 14.62%
191,253 $16.4 Million
Q3 2023

May 14, 2024
SELL
$82.56 - $93.49 $2.01 Million - $2.28 Million
-24,394 Reduced 12.75%
166,859 $14.9 Million
Q3 2023

Nov 14, 2023
SELL
$82.56 - $93.49 $2.39 Million - $2.71 Million
-28,983 Reduced 14.8%
166,859 $14.9 Million
Q2 2023

May 14, 2024
BUY
$80.84 - $89.45 $1.45 Million - $1.6 Million
17,933 Added 10.08%
195,842 $16.7 Million
Q2 2023

Aug 14, 2023
BUY
$80.84 - $89.45 $1.45 Million - $1.6 Million
17,933 Added 10.08%
195,842 $16.7 Million
Q1 2023

May 14, 2024
SELL
$72.75 - $90.6 $5.16 Million - $6.42 Million
-70,894 Reduced 28.49%
177,909 $14.7 Million
Q1 2023

May 11, 2023
SELL
$72.75 - $90.6 $5.16 Million - $6.42 Million
-70,894 Reduced 28.49%
177,909 $14.7 Million
Q4 2022

May 14, 2024
BUY
$73.85 - $86.14 $7.99 Million - $9.32 Million
108,252 Added 77.02%
248,803 $19.6 Million
Q4 2022

Feb 13, 2023
BUY
$73.85 - $86.14 $7.99 Million - $9.32 Million
108,252 Added 77.02%
248,803 $19.6 Million
Q3 2022

May 14, 2024
BUY
$63.3 - $78.66 $2.79 Million - $3.46 Million
44,034 Added 45.62%
140,551 $10.4 Million
Q3 2022

Nov 10, 2022
BUY
$63.3 - $78.66 $2.79 Million - $3.46 Million
44,034 Added 45.62%
140,551 $10.4 Million
Q2 2022

May 14, 2024
SELL
$49.27 - $66.08 $4.67 Million - $6.26 Million
-94,736 Reduced 49.53%
96,517 $6.29 Million
Q2 2022

Aug 15, 2022
SELL
$49.27 - $66.08 $1.48 Million - $1.99 Million
-30,113 Reduced 23.78%
96,517 $6.29 Million
Q1 2022

May 16, 2022
BUY
$43.77 - $63.22 $442,558 - $639,217
10,111 Added 8.68%
126,630 $8.01 Million
Q4 2021

Feb 14, 2022
BUY
$49.55 - $74.59 $658,866 - $991,823
13,297 Added 12.88%
116,519 $6.18 Million
Q3 2021

Nov 10, 2021
BUY
$57.6 - $70.59 $5.95 Million - $7.29 Million
103,222 New
103,222 $7.29 Million

Others Institutions Holding HAE

# of Institutions
337
Shares Held
55.7M
Call Options Held
383K
Put Options Held
45.1K
View Full List

About HAEMONETICS CORP

HAE Quotes by TradingView
  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.65B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email